Clinical Research Directory
Browse clinical research sites, groups, and studies.
Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement
Sponsor: Horus University
Summary
This study aims to rigorously assess the effectiveness of LPCGF in the management of internal disc displacement in patients with TMD through a randomized clinical trial. By comparing LPCGF therapy with conventional arthrocentesis, this research looks to provide robust evidence on the efficacy, safety, and potential role of (LPCGF) as an alternative therapeutic choice for IDD.
Official title: Injection of Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Management of Temporomandibular Disc Displacement: A Randomized Controlled Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2025-10-01
Completion Date
2026-06-01
Last Updated
2026-03-11
Healthy Volunteers
Yes
Conditions
Interventions
Liquid Phase Concentrated Growth Factor
16 patients with anterior disc displacement with or without reduction randomly allocated to be treated with injection of liquid phase concentrated growth factor
Conventional arthrocentesis
16 patients with anterior disc displacement with or without reduction randomly allocated to be treated with conventional arthrocentesis
Locations (1)
Faculty of Dentistry- Horus University in Egypt
Damietta, New Damietta, Egypt